1Piao G, Wu J. Systematic assessment of dexmedetomidine as an anesthetic agent: a recta-analysis of randomized coutrolled trials J]. Arch M ed Sci, 2014, 10 ( 1 ) : 19-24. DOI: 10.5ll4/aoms. 2014.40730.
2Ebert TJ, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans[ J]. Anes- thesiology, 2000,93 (2) : 382-394.
3Venn RM, Karol MD, Grounds RM. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive caret [ J ]. Br 3 Anaesth, 2002, $8 ( 5 ) : 669- 675. DOI : 10.1093/bja/88.5.669.
5Wu XM, Wang TL, Xue ZG, ct al. Guidance for clinical ap- plication of dexmedetmnidine (2013) [ J]. Chin J Anesthesiol, 2013,30(10) : 1165-1167.DOI: 10.3760/ema.j.issn.0254-1416. 2013.10.001.
6Klinger RY, White WD, Hale B, et al. Hemodynamic impact of dexmedetomidine administration in 15, 656 noncardiac surgical cases[J]. J Clin Anesth,2012,24(3):212-220.DOI:10.1016/j. jclinane.2011.07.016.
